Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Improving surgical access for patients with primary hyperparathyroidism

Official title: Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism

Run by University of Pennsylvania · NCT06562881 · Data updated 2026-11-12

This study is testing if helping patients with primary hyperparathyroidism get better support and guidance can improve their chances of getting timely surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment76 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedAugust 27, 2026
Trial IDNCT06562881 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with primary hyperparathyroidism who belong to racial or ethnic minority groups and meet specific clinical criteria for surgical treatment.

Probably not a fit

Patients who have previously undergone parathyroidectomy or have end-stage renal disease may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance surgical health equity for historically marginalized patients diagnosed with primary hyperparathyroidism (PHPT) by implementing patient navigation strategies. It investigates how these navigation efforts, including direct outreach and appointment scheduling, affect the rates of surgical consultations and surgeries among participants. The study will randomize participants to receive or not receive navigation support, with a crossover design allowing those initially not receiving navigation to access it after three months. The focus is on improving timely access to parathyroidectomy, a curative and low-risk surgery for PHPT.

Why it matters

Potential benefit: If successful, this study could significantly increase the rates of surgical treatment for marginalized patients with primary hyperparathyroidism, improving their quality of life.

How similar studies have gone: Other studies have shown success in using patient navigation to improve access to surgical care, indicating that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with PHPT and not yet had parathyroidectomy who meet criteria for surgical treatment of PHPT (osteoporosis, fragility fracture, or evidence of vertebral compression fracture on spine imaging, renal involvement \[renal stone, silent nephrolithiasis on renal imaging, nephrocalcinosis, hypercalciuria (24-hour urine calcium level 400 mg/dL) with increased stone risk, or impaired renal function (glomerular filtration rate 60 mL/min)\], calcium 1 mg/dL above upper limit of normal, age less than 50)
* Qualify as a member of a racial or ethnic minority group (Black, Hispanic, Asian and Pacific Islander, Native American), lower socioeconomic neighborhoods (by zipcode), socially vulnerable (social determinants of health indicating financial strain, social vulnerability index in the top quartile 75%+ by zip code), or with underinsurance (Medicaid, Medicare, dual eligible, uninsured)

Exclusion Criteria:

* Prior Parathyroidectomy
* End-stage Renal Disease
* Renal Transplant
* Vitamin D Deficiency
* Metastatic Disease
* Familial Hypocalciuric Hypercalcemia
* No Indication for Surgery
* Unable/Unwilling to provide consent

Where it's running

  • Hospital of the University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.